from PharmacoEconomics at http://bit.ly/2FdbyJ1 on April 25, 2018 at 04:15AM
Abstract
The manufacturer of the calcimimetic drug etelcalcetide was invited to make an evidence submission as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) programme. 377 more words